05/08/2019
https://congress.gov...
"I think it is indefensible and there is going to be a lot of continued inquiry in that regard."
"I think HHS and FDA have to put a plan in place for retroactively reviewing the safety and efficacy of existing opioid projects."
"I just wanted to make sure the record was clear on a couple of things."
"So how is HHS going to hold pharmaceutical manufacturers accountable for drug-marketing strategies that are boosting profits while harming our communities?"